Singapore-based biotech company CellResearch Corporation, the owners of cord-lining stem cell-based cosmeceutical, Calecim Professional, has awarded exclusive distribution rights in Italy to pharmaceutical company Giuliani.
Gavin Tan, chief executive officer of CellResearch Corporation commented on this partnership, “This announcement marks an important step forward for Calecim Professional in one of the world’s biggest aesthetic markets. I am delighted that we have reached this agreement with such a renowned partner to increase the brand’s presence in this part of the world. It is an exciting start to 2019 and we mean to continue in a similar fashion throughout the year.”
Stefano Franceschi, international markets director at Giuliani, added, “This partnership is an important strategic expansion of our cosmetic portfolio. A partnership with Calecim Professional is in line with our strategy of providing innovative healthcare and medical aesthetics solutions. We are excited about the tremendous potential of Calecim’s unique stem cell technology and what it can bring to the Italian market.”